NCT03708211 - A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

December 3, 2019

Study Completion Date

December 3, 2019

Conditions

Neoplasms, Advanced Solid

Interventions

DRUG

TAK-931 PIC

TAK-931 PICs.

DRUG

TAK-931 Tablet

TAK-931 Tablets.

DRUG

Esomeprazole

Esomeprazole Tablets.

Trial Locations (4)

Radboud University Medical Center, Department of Medical Oncology, Nijmegen

Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Medical Oncology, Amsterdam

Leiden University Medical Center, Department of Clinical Oncology, Leiden

Erasmus MC Cancer Institute, Department of Internal Oncology, Rotterdam